Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | dihydrofolate reductase | Starlite/ChEMBL | References |
Homo sapiens | thymidylate synthetase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | dihydrofolate reductase | 187 aa | 202 aa | 29.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | dihydrofolate reductase | 0.0208 | 0.5242 | 0.4572 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0111 | 0.1234 | 0.0824 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0274 | 0.8012 | 0.7732 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0111 | 0.1234 | 0.0824 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0111 | 0.1234 | 0.1234 |
Treponema pallidum | NADH oxidase | 0.0111 | 0.1234 | 0.5 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0322 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0111 | 0.1234 | 0.0824 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0274 | 0.8012 | 0.7732 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0111 | 0.1234 | 0.0824 |
Mycobacterium ulcerans | thymidylate synthase | 0.0195 | 0.4702 | 0.8654 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0208 | 0.5242 | 0.1018 |
Brugia malayi | dihydrofolate reductase family protein | 0.0208 | 0.5242 | 0.5242 |
Plasmodium falciparum | thioredoxin reductase | 0.0322 | 1 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0322 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0111 | 0.1234 | 0.0824 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0208 | 0.5242 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0111 | 0.1234 | 0.5 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0195 | 0.4702 | 0.3957 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0111 | 0.1234 | 0.0824 |
Brugia malayi | Dihydrofolate reductase | 0.0208 | 0.5242 | 0.5242 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0111 | 0.1234 | 0.0824 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0322 | 1 | 1 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0208 | 0.5242 | 0.5019 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0111 | 0.1234 | 0.0824 |
Toxoplasma gondii | thioredoxin reductase | 0.0322 | 1 | 1 |
Schistosoma mansoni | dihydrofolate reductase | 0.0208 | 0.5242 | 0.4572 |
Brugia malayi | thymidylate synthase | 0.0195 | 0.4702 | 0.4702 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0322 | 1 | 1 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0208 | 0.5242 | 0.4572 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0208 | 0.5242 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0322 | 1 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0322 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0093 | 0.0447 | 0.0447 |
Plasmodium vivax | glutathione reductase, putative | 0.0322 | 1 | 1 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0274 | 0.8012 | 0.7732 |
Loa Loa (eye worm) | glutathione reductase | 0.0322 | 1 | 1 |
Onchocerca volvulus | 0.0195 | 0.4702 | 0.5 | |
Plasmodium vivax | thioredoxin reductase, putative | 0.0322 | 1 | 1 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.0208 | 0.5242 | 1 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0111 | 0.1234 | 0.0824 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0195 | 0.4702 | 0.4455 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0111 | 0.1234 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0111 | 0.1234 | 0.5 |
Echinococcus granulosus | thymidylate synthase | 0.0195 | 0.4702 | 0.3957 |
Leishmania major | trypanothione reductase | 0.0322 | 1 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0274 | 0.8012 | 0.7732 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0195 | 0.4702 | 0.8654 |
Echinococcus multilocularis | thymidylate synthase | 0.0195 | 0.4702 | 0.3957 |
Trypanosoma brucei | trypanothione reductase | 0.0322 | 1 | 1 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0111 | 0.1234 | 0.0824 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0274 | 0.8012 | 0.7919 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0111 | 0.1234 | 0.0824 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0274 | 0.8012 | 0.7732 |
Brugia malayi | Thioredoxin reductase | 0.0322 | 1 | 1 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0111 | 0.1234 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0111 | 0.1234 | 0.0824 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0111 | 0.1234 | 0.5 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0111 | 0.1234 | 0.0824 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | > 100 uM | Effective dose which is required to inhibit 50% of the cell growth of MCF-7 cells in culture. | ChEMBL. | 1995883 |
ED50 (functional) | > 100 uM | Effective dose which is required to inhibit 50% of the cell growth of MCF-7 cells in culture. | ChEMBL. | 1995883 |
I50 (binding) | = 0.21 uM | Inhibition of dihydrofolate reductase (DHFR) in WIL2 cells | ChEMBL. | 1995883 |
I50 (binding) | = 7.1 uM | Inhibition of thymidylate synthase (TS) in human | ChEMBL. | 1995883 |
I50 (binding) | = 62.8 uM | Inhibition of 5-aminoimidazole-4-carboxamide AICAR formyltransferase in MOLT-4 cells | ChEMBL. | 1995883 |
I50 (binding) | = 85.9 uM | Inhibition of GAR transformylase in hog liver | ChEMBL. | 1995883 |
IC50 (binding) | = 0.21 uM | Inhibition of dihydrofolate reductase (DHFR) in WIL2 cells | ChEMBL. | 1995883 |
IC50 (binding) | = 7.1 uM | Inhibition of thymidylate synthase (TS) in human | ChEMBL. | 1995883 |
IC50 (binding) | = 62.8 uM | Inhibition of 5-aminoimidazole-4-carboxamide AICAR formyltransferase in MOLT-4 cells | ChEMBL. | 1995883 |
IC50 (binding) | = 85.9 uM | Inhibition of GAR transformylase in hog liver | ChEMBL. | 1995883 |
Ki (functional) | > 30 uM | Inhibition of the uptake of [3H]-MTX influx into MOLT-4 cells. | ChEMBL. | 1995883 |
Ki (functional) | > 30 uM | Inhibition of the uptake of [3H]-MTX influx into MOLT-4 cells. | ChEMBL. | 1995883 |
Km app (binding) | = 133 uM | Compound was evaluated for the substrate activity for hog liver Folyl-polyglutamate synthase | ChEMBL. | 1995883 |
Ratio (ADMET) | = 0.23 | Ratio of relative Vmax values to that of apparent Km values. | ChEMBL. | 1995883 |
Relative Vmax (ADMET) | = 31.3 | Maximum drug concentration (Vmax), relative to a control of 50 uM aminopterin included in each experiment. | ChEMBL. | 1995883 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.